US14149Y1082 - Common Stock
NYSE:CAH (8/10/2022, 1:56:00 PM)+0.73 (+1.18%)
GICS Sector | Health Care | ||
GICS Industry | Health Care Providers & Services |
Valuation | Growth | ||
Profitability | Health | ||
Dividend |
Earnings (Last) | 05-05 2022-05-05/bmo | Earnings (Next) | 08-11 2022-08-11/bmo |
Ins Owners | 0.44% | Inst Owners | 86.48% |
Market Cap | 17.03B | Shares | 272.43M |
PE | 11.77 | Fwd PE | 11.4 |
Dividend Yield | 3.46% | Analysts | 67 |
IPO | 08-04 1983-08-04 |
Find more stocks on New York Stock Exchange, Inc.
Find more stocks on the USA
Find competitors from the same sector on the USA
Find competitors from the same industry on the USA
Find stocks with similar TA and Setup ratings on the USA
Find stocks with similar Fundamental rating on the USA
Find the competitors with the best technical ratings on the USA
Find the competitors with the best technical and setup ratings on the USA
Find the competitors with the best fundamentals on the USA
Find the competitors with the best valuation on the USA
Find the competitors with the best dividend on the USA
Find the competitors with the best analyst ratings on the USA
Cardinal Health, Inc. is a healthcare services and products company, which engages in the provision of customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices. The company is headquartered in Dublin Ohio, Ohio and currently employs 47,300 full-time employees. The firm operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; provides pharmacy management services to hospitals; and repackages generic pharmaceuticals and over-the-counter healthcare products. The Medical segment manufactures, sources and distributes a range of medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. This segment also distributes a range of national brand products and provides supply chain services and solutions to hospitals and other healthcare providers.
CARDINAL HEALTH INC
7000 Cardinal Pl
Dublin Ohio OHIO 43017
P: 16147573033.0
CEO: Michael C. Kaufmann
Employees: 47300
/PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that Michelle Greene has been named chief information officer. Greene will report to CEO, Mike...
Digital Health Startup Is Tackling Medication Mismanagement, a $500 Billion Problem
Cardinal Health sees its Relative Strength Rating enter the 80-plus level.
This red-hot stock leads its industry group, is highly rated and topped a buy point.
Here you can normally see the latest stock twits on CAH, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: